This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heipertz, R. A.
Right arrow Articles by Isom, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heipertz, R. A., Jr.
Right arrow Articles by Isom, H. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

 Previous Article  |  Next Article 

Journal of Virology, April 2007, p. 3068-3076, Vol. 81, No. 7
0022-538X/07/$08.00+0     doi:10.1128/JVI.02341-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

In Vitro Study of the Effects of Precore and Lamivudine-Resistant Mutations on Hepatitis B Virus Replication{triangledown}

Richard A. Heipertz Jr.,1 Thomas G. Miller,1 Colleen M. Kelley,1 William E. Delaney IV,2,{dagger} Stephen A. Locarnini,2 and Harriet C. Isom1,3*

Department of Microbiology and Immunology,1 Department of Pathology, Milton S. Hershey Medical Center, The Penn State College of Medicine, Hershey, Pennsylvania 17033,3 Victorian Infectious Disease Reference Laboratory, North Melbourne, Victoria, Australia2

Received 25 October 2006/ Accepted 3 January 2007

Understanding the consequences of mutation in the hepatitis B virus (HBV) genome on HBV replication is critical for treating chronic HBV infection. In this study, HBV replication in HepG2 cells initiated by transduction with precore (PC), rtM204I, and wild-type (wt) HBV recombinant baculoviruses was compared. The pattern and magnitude of HBV replication initiated by the PC HBV recombinant baculovirus were similar to those observed for wt HBV throughout the time course examined. In contrast, when the rtM204I mutation was introduced into wt HBV, by day 10 postinfection the levels of intra- and extracellular HBV DNA were markedly reduced compared to those for wt HBV. Although the rtM204I mutation reduced the production of HBV replicative intermediates, no effect on the level of covalently closed circular DNA or HBV transcripts was observed at late time points. Coinfection studies with different ratios of wt and rtM204I baculoviruses showed that the rtM204I variant did not produce a product that inhibited HBV replication. However, the combination of the wt and rtM204I baculoviruses yielded HBV DNA levels at late time points that were greater than those for the wt alone, suggesting that wt polymerase may function in trans to boost rtM204I replication. We concluded that the rtM204I mutation generates a polymerase that is not only resistant to lamivudine but also replicates nucleic acids to lower levels in vitro.


* Corresponding author. Mailing address: Milton S. Hershey Medical Center, The Penn State College of Medicine, 500 University Drive, P.O. Box 850, Hershey, PA 17033. Phone: (717) 531-8609. Fax: (717) 531-4133. E-mail: hisom{at}psu.edu.

{triangledown} Published ahead of print on 10 January 2007.

{dagger} Present address: Gilead Sciences, Foster City, CA 94404.


Journal of Virology, April 2007, p. 3068-3076, Vol. 81, No. 7
0022-538X/07/$08.00+0     doi:10.1128/JVI.02341-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Starkey, J. L., Chiari, E. F., Isom, H. C. (2009). Hepatitis B virus (HBV)-specific short hairpin RNA is capable of reducing the formation of HBV covalently closed circular (CCC) DNA but has no effect on established CCC DNA in vitro. J. Gen. Virol. 90: 115-126 [Abstract] [Full Text]